Bioregulator Research
Epitalon (Epithalon)
BioHarmony verdict
Worth trying
Epitalon is a synthetic AEDG tetrapeptide with in vitro telomerase and telomere data, animal lifespan signals, and Russian pineal-peptide melatonin studies. The score stays 6.5-7.0/10 because the strongest human claims are not independently replicated, and the 2025 Al-dulaimi paper adds mechanistic support plus cancer-cell ALT caution.
Read full reportWhat is Epitalon (Epithalon)?
Epitalon, also called Epithalon or AEDG, is a synthetic four-amino-acid peptide modeled after epithalamin, a pineal-gland peptide extract from the Russian bioregulator tradition. Its core claim is unusual: a short peptide cycle may influence telomerase, telomere length, melatonin rhythm, and age-related neuroendocrine decline. Khavinson 2003 reported telomerase activity and telomere elongation in cultured human somatic cells, while Al-dulaimi 2025 independently found telomere-length extension in normal epithelial and fibroblast cells and in breast-cancer cell lines.
From the BioHarmony report, reviewed 2026-09-08.
Safety watch-outs
- Injection-site infection
- New severe headache or neurological symptoms
Full risk profile in the BioHarmony report.
Dosing as published
No approved-label or study protocol is recorded for Epitalon (Epithalon) yet.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (5)
Attributed viewpoints, separate from primary research.
- International Peptide Society 2018 Compound CurriculumDr. William Seeds · 2018-07-20
- Peptides to Promote Cellular HealthDr. Suzanne Ferree · 2025-09-15
- Epitalon, The Telomere Lengthening Peptide | How To Use ItHunter Williams · 2026-04-08
- Epitalon Peptide Benefits, Dosage & Side EffectsJay Campbell · 2026-04-29
- Peptides for Anti Aging & InjuryJean-François Tremblay · 2018-09-22
Trust & sourcing
FDA identifies potential immunogenicity and peptide-impurity risks for compounded epitalon and says proposed-route safety information is insufficient.
Primary sources
- Certain bulk drug substances for use in compounding that may present significant safety risksU.S. Food and Drug Administration · 2026-04-22
Related peptides for brain, mood & sleep
Free guide
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.